Julie Ducharme, MD
Endocrinology, Diabetes & Metabolism · Havre de Grace, MDNPI 1033250048
Payments from drug & device makers
Across 423 payments — averaging $54.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$17K
- Novo Nordisk$937
- AbbVie$771
- Amgen$656
- Sanofi-aventis U.S. LLC$565
- Corcept Therapeutics$334
- plus $3K from 36 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 76 | $16,546 |
| Novo Nordisk | 68 | $937 |
| AbbVie | 48 | $771 |
| Amgen(2 entities) | 29 | $656 |
| Sanofi-aventis U.S. LLC | 31 | $565 |
| Corcept Therapeutics | 19 | $334 |
| Radius Health, Inc. | 12 | $319 |
| AstraZeneca(2 entities) | 14 | $252 |
| Amneal Pharmaceuticals LLC | 18 | $238 |
| IBSA Pharma Inc. | 10 | $215 |
| Insulet Corporation | 7 | $187 |
| Medtronic(2 entities) | 9 | $163 |
| Abbott | 9 | $162 |
| Baxter Healthcare | 1 | $149 |
| Antares Pharma, Inc. | 7 | $139 |
| Cequr Corporation | 2 | $117 |
| Amarin Pharma, Inc. | 5 | $110 |
| Merck | 7 | $108 |
| Tandem Diabetes Care, Inc. | 6 | $105 |
| Novartis | 5 | $93 |
| Xeris Pharmaceuticals, Inc. | 4 | $89 |
| Dexcom, Inc. | 5 | $86 |
| BD | 3 | $81 |
| Pfizer | 3 | $64 |
| Boehringer Ingelheim | 3 | $60 |
| Embecta Corp. | 2 | $56 |
| Johnson & Johnson | 2 | $46 |
| Bayer | 2 | $43 |
| Mannkind Corporation | 2 | $42 |
| Neurocrine Biosciences, Inc. | 1 | $40 |
| Lifescan, Inc. | 2 | $39 |
| BETA Bionics, Inc. | 1 | $35 |
| Sequel Med Tech, LLC | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Senseonics, Incorporated | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Clarus Therapeutics Inc. | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Companion Medical, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Intuity Medical Inc | 1 | $14 |
How this compares
$23,047 in reported general payments places this provider in the 80th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.
See all endocrinology, diabetes & metabolism providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Havre de Grace
- Jean ParkBaltimore$3.7M
- Michael DempseyRockville$2.7M
- Ilias SpanakisBaltimore$2.6M
- Helena RodbardRockville$2.4M
- Daniel GozziSuitland$1.2M
- Martin SarkarFrederick$1.1M
- Romeu AzevedoCamp Springs$1.1M
- Nicholas ArgentoLaurel$1.1M
- Philip LevinBaltimore$702K
- David BrownRockville$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.